Stay updated on IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.0%
    Check dated 2026-03-12T20:27:10.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Minor UI/version change: the page footer now shows Revision: v3.4.2, replacing v3.4.1; this does not affect core content, data, or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T03:49:41.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1; a minor UI update that does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T01:27:15.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Glossary is now shown to help users understand trial terms. Minor metadata updates include capitalization adjustments for QC-related labels and a new Revision: v3.4.0 entry.
    Difference
    0.2%
    Check dated 2026-01-28T21:26:16.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Minor update to page revision label: addition of Revision v3.3.4 and removal of Revision v3.3.3, which does not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T03:27:43.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    The page now includes a detailed Locations section with state-specific sites (CA, GA, KY, MO, NJ, PA, SC, TN, UT, VT) and a revision note indicating v3.3.3. The HHS Vulnerability Disclosure link and references to v3.3.2 were removed.
    Difference
    1%
    Check dated 2025-12-23T22:23:02.000Z thumbnail image

Stay in the know with updates to IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IDO Inhibitor+Gem/Nab-Pac in Metastatic Pancreatic Cancer Clinical Trial page.